dihexa metabolic stability compared to angiotensin iv Evaluation of Metabolically Stabilized Analogs as Procognitive/Antidementia Agents Dihexa (also known as PNB-0408)
Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted DPP (Dipeptidyl Peptidase) 4 Inhibitor Attenuates Ang II (Angiotensin II)Induced Cardiac Hypertrophy via GLP (Glucagon Like Peptide) 1Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4 HDAC (Histone Deacetylase) 4 PDF) Evaluation of Metabolically Stabilized Angiotensin IV Analogs as Procognitive Antidementia Agents Clinical and preclinical evidence that angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent diabetic peripheral neuropathy Scientific Reports
Pay in 4 interest-free payments of $5.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30


